Dsuvia
Started by Gas
The FDA has approved a new sublingual formulation of sufentanil, Dsuvia, for the management of acute pain in adults in medically supervised healthcare settings, such as hospitals, surgical centers, and emergency departments. The drug is supplied in a 30 microgram tablet in a single-dose, prefilled applicator for administration by a healthcare professional, and it will not be available in retail pharmacies or for outpatient use.
www.ajmc.com
I see no role for this drug in my practice or anyone's practice for that matter. It's role is for use where IV medications can not be administered like the battlefield.
FDA Approves Painkiller Dsuvia Amid Criticism | AJMC
The FDA has approved a new sublingual formulation of sufentanil, Dsuvia, for the management of acute pain in adults in medically supervised healthcare settings, such as hospitals, surgical centers, and emergency departments. The drug is supplied in a 30 microgram tablet in a single-dose...
I see no role for this drug in my practice or anyone's practice for that matter. It's role is for use where IV medications can not be administered like the battlefield.
The FDA has approved a new sublingual formulation of sufentanil, Dsuvia, for the management of acute pain in adults in medically supervised healthcare settings, such as hospitals, surgical centers, and emergency departments. The drug is supplied in a 30 microgram tablet in a single-dose, prefilled applicator for administration by a healthcare professional, and it will not be available in retail pharmacies or for outpatient use.
FDA Approves Painkiller Dsuvia Amid Criticism | AJMC
The FDA has approved a new sublingual formulation of sufentanil, Dsuvia, for the management of acute pain in adults in medically supervised healthcare settings, such as hospitals, surgical centers, and emergency departments. The drug is supplied in a 30 microgram tablet in a single-dose...
I see no role for this drug in my practice or anyone's practice for that matter. It's role is for use where IV medications can not be administered like the battlefield.
Yea, we've had a rep trying to push this one on us, but agreed. There's zero role for it in a standard anesthesia practice.
Advertisement - Members don't see this ad
Yes, the "FDA’s Anesthetic and Analgesic Drug Products Committee" held a vote during ASA 2018 when Dr Brown and numerous others who were against it explicitly said they would not be able to make the vote due to the national conference.The FDA has approved a new sublingual formulation of sufentanil, Dsuvia, for the management of acute pain in adults in medically supervised healthcare settings, such as hospitals, surgical centers, and emergency departments. The drug is supplied in a 30 microgram tablet in a single-dose, prefilled applicator for administration by a healthcare professional, and it will not be available in retail pharmacies or for outpatient use.
FDA Approves Painkiller Dsuvia Amid Criticism | AJMC
The FDA has approved a new sublingual formulation of sufentanil, Dsuvia, for the management of acute pain in adults in medically supervised healthcare settings, such as hospitals, surgical centers, and emergency departments. The drug is supplied in a 30 microgram tablet in a single-dose...
I see no role for this drug in my practice or anyone's practice for that matter. It's role is for use where IV medications can not be administered like the battlefield.
I think it should be used for low back pain and muscle spasm
At the earliest sign or even hint of pain, pop the sublingual. I’m thinking if we can stop the pain before it starts, we can get rid of the chronic low back pain epidemic.
At the earliest sign or even hint of pain, pop the sublingual. I’m thinking if we can stop the pain before it starts, we can get rid of the chronic low back pain epidemic.
